Inflammatory responses in SARS-CoV-2 associated multisystem inflammatory syndrome and Kawasaki Disease in children: an observational study

Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD). We hypothesized that MIS-C and KD might have commo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS ONE 2022-11, Vol.17 (11)
Hauptverfasser: Biesbroek, G., Kapitein, B., Kuipers, I.M., Gruppen, M.P., Stijn, D. van, Peros, T.E., Veenendaal, M. van, Jansen, M.H.A., Zee, C.W. van der, Kuip, M. van der, Asmuth, E.G.J. von, Mooij, M.G., Boer, M.E.J. den, Landman, G.W., Houten, M.A. van, Schonenberg-Meinema, D., Furth, A.M.T. van, Hensbroek, M.B. van, Scherpbier, H., Meijgaarden, K.E. van, Ottenhoff, T.H.M., Joosten, S.A., Ketharanathan, N., Blink, M., Brackel, C.L.H., Zaaijer, H.L., Hombrink, P., Berg, J.M. van den, Buddingh, E.P., Kuijpers, T.W.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe inflammatory disease in children related to SARS-CoV-2 with multisystem involvement including marked cardiac dysfunction and clinical symptoms that can resemble Kawasaki Disease (KD). We hypothesized that MIS-C and KD might have commonalities as well as unique inflammatory responses and studied these responses in both diseases. In total, fourteen children with MIS-C (n=8) and KD (n=6) were included in the period of March-June 2020. Clinical and routine blood parameters, cardiac follow-up, SARS-CoV-2-specific antibodies and CD4+ T-cell responses, and cytokine-profiles were determined in both groups. In contrast to KD patients, all MIS-C patients had positive Spike protein-specific CD3(+) CD4(+) T-cell responses. MIS-C and KD patients displayed marked hyper-inflammation with high expression of serum cytokines, including the drug-targetable interleukin (IL)-6 and IFN-gamma associated chemokines CXCL9, 10 and 11, which decreased at follow-up. No statistical differences were observed between groups. Clinical outcomes were all favourable without cardiac sequelae at 6 months follow-up. In conclusion, MIS-C and KD-patients both displayed cytokine-associated hyper-inflammation with several high levels of drug-targetable cytokines.